U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07460440) titled 'SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier' on March 03.
Brief Summary: The purpose of this study is to test whether combining a unique analytical approach with changes in platelet RNA expression accurately diagnoses lung cancer. Using retrospective platelet transcriptomic data from 522 patients with non-small cell lung cancer (NSCLC, the most common type of lung cancer), an approach that appears to accurately classify lung cancer has been developed.
The study will build upon these retrospective analyses to prospectively recruit patients with newly diagnosed lung cancer, obtain platelet...